Literature DB >> 18449888

Variants in DNA double-strand break repair and DNA damage-response genes and susceptibility to lung and head and neck cancers.

Patrick Danoy1, Stefan Michiels2,3, Philippe Dessen4, Cécile Pignat1, Thomas Boulet2, Marion Monet1, Christine Bouchardy5, Mark Lathrop1, Alain Sarasin4, Simone Benhamou3,4.   

Abstract

Cigarette smoking is the major risk factor for lung cancer, and together with alcohol for head and neck (H--N) cancer. These genotoxics produced DNA damage and particularly double-strand breaks (DSB) that are removed by various repair pathways. To understand the initiation of these cancers, we performed a genotype analysis to correlate some variants in specific genes in a case-control study of lung and H-N cancers. In a discovery phase, we sequenced DNA samples of 32 healthy Caucasians to describe genetic variants in 30 genes involved in the repair of DSB and in DNA damage response. 625 variants were detected on 29 out of the 30 genes successfully screened by sequencing exons, parts of introns and flanking regions. These included 470 non-exonic variants, from which 33 insertions/deletions, and 155 exonic alterations, corresponding to 59 non synonymous polymorphisms. 223 of these variants were not previously described. In total, 379 variants were successfully genotyped in a case-control study restricted to smokers including 151 lung cases, 251 H-N cases, and 172 controls. To account for multiple testing, we associated to each p-value a proportion of false positives (q-value). Haplotype-analysis suggested potential associations (p < 0.05) between lung cancer and 2 genes (RECQL4 and RAD52), which came with q-value of 8%, and between H-N cancer and 1 gene (DNA-PK) but with q-value of 56%. The 3 genes are key players for regulating the efficiency of DSB repair. Large-scale studies are needed to show if any of these 3 variants are truly associated with an increased risk of cancer. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18449888     DOI: 10.1002/ijc.23524

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  13 in total

Review 1.  Human Papillomavirus Laboratory Testing: the Changing Paradigm.

Authors:  Eileen M Burd
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

2.  Evaluation of miRNA-binding-site SNPs of MRE11A, NBS1, RAD51 and RAD52 involved in HRR pathway genes and risk of breast cancer in China.

Authors:  Zhenzhen Wu; Peng Wang; Chunhua Song; Kaijuan Wang; Rui Yan; Jingruo Li; Liping Dai
Journal:  Mol Genet Genomics       Date:  2015-01-09       Impact factor: 3.291

3.  An analysis of single nucleotide polymorphisms of 125 DNA repair genes in the Texas genome-wide association study of lung cancer with a replication for the XRCC4 SNPs.

Authors:  Hongping Yu; Hui Zhao; Li-E Wang; Younghun Han; Wei V Chen; Christopher I Amos; Thorunn Rafnar; Patrick Sulem; Kari Stefansson; Maria Teresa Landi; Neil Caporaso; Demetrius Albanes; Michael Thun; James D McKay; Paul Brennan; Yufei Wang; Richard S Houlston; Margaret R Spitz; Qingyi Wei
Journal:  DNA Repair (Amst)       Date:  2011-02-05

4.  Evaluating the association of polymorphisms in the HAP1 gene with lung cancer risk: a meta-analysis.

Authors:  Wei Wang; Haicheng Yan; Qiang Zhang; Wei Song; Haina Li; Jun Xu
Journal:  Tumour Biol       Date:  2014-08-01

5.  A RAD52 genetic variant located in a miRNA binding site is associated with glioma risk in Han Chinese.

Authors:  Chao Lu; Yi-Dong Chen; Sichong Han; Jinyu Wei; Yunxia Ge; Wenting Pan; Tao Jiang; Xiao-Guang Qiu; Ming Yang
Journal:  J Neurooncol       Date:  2014-07-11       Impact factor: 4.130

6.  Inherited variation at chromosome 12p13.33, including RAD52, influences the risk of squamous cell lung carcinoma.

Authors:  Jianxin Shi; Nilanjan Chatterjee; Melissa Rotunno; Yufei Wang; Angela C Pesatori; Dario Consonni; Peng Li; William Wheeler; Peter Broderick; Marc Henrion; Timothy Eisen; Zhaoming Wang; Wei Chen; Qiong Dong; Demetrius Albanes; Michael Thun; Margaret R Spitz; Pier Alberto Bertazzi; Neil E Caporaso; Stephen J Chanock; Christopher I Amos; Richard S Houlston; Maria Teresa Landi
Journal:  Cancer Discov       Date:  2011-12-07       Impact factor: 39.397

7.  Strain background determines lymphoma incidence in Atm knockout mice.

Authors:  Paula C Genik; Helle Bielefeldt-Ohmann; Xianan Liu; Michael D Story; Lianghao Ding; Jamie M Bush; Christina M Fallgren; Michael M Weil
Journal:  Neoplasia       Date:  2014-02       Impact factor: 5.715

Review 8.  A Decade of GWAS Results in Lung Cancer.

Authors:  Yohan Bossé; Christopher I Amos
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-06-14       Impact factor: 4.254

9.  Influence of common genetic variation on lung cancer risk: meta-analysis of 14 900 cases and 29 485 controls.

Authors:  Maria N Timofeeva; Rayjean J Hung; Thorunn Rafnar; David C Christiani; John K Field; Heike Bickeböller; Angela Risch; James D McKay; Yufei Wang; Juncheng Dai; Valerie Gaborieau; John McLaughlin; Darren Brenner; Steven A Narod; Neil E Caporaso; Demetrius Albanes; Michael Thun; Timothy Eisen; H-Erich Wichmann; Albert Rosenberger; Younghun Han; Wei Chen; Dakai Zhu; Margaret Spitz; Xifeng Wu; Mala Pande; Yang Zhao; David Zaridze; Neonilia Szeszenia-Dabrowska; Jolanta Lissowska; Peter Rudnai; Eleonora Fabianova; Dana Mates; Vladimir Bencko; Lenka Foretova; Vladimir Janout; Hans E Krokan; Maiken Elvestad Gabrielsen; Frank Skorpen; Lars Vatten; Inger Njølstad; Chu Chen; Gary Goodman; Mark Lathrop; Simone Benhamou; Tõnu Vooder; Kristjan Välk; Mari Nelis; Andres Metspalu; Olaide Raji; Ying Chen; John Gosney; Triantafillos Liloglou; Thomas Muley; Hendrik Dienemann; Gudmar Thorleifsson; Hongbing Shen; Kari Stefansson; Paul Brennan; Christopher I Amos; Richard Houlston; Maria Teresa Landi
Journal:  Hum Mol Genet       Date:  2012-08-16       Impact factor: 6.150

10.  The checkpointkinase 2 (CHK2) 1100delC germ line mutation is not associated with the development of squamous cell carcinoma of the head and neck (SCCHN).

Authors:  Kathrin Scheckenbach; Galatia Papadopoulou; Thomas K Hoffmann; Adam Chaker; Henning Bier; Jörg Schipper; Vera Balz; Martin Wagenmann
Journal:  J Negat Results Biomed       Date:  2010-12-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.